Velan Capital Investment Management LP Intra Cellular Therapies, Inc. Transaction History
Velan Capital Investment Management LP
- $48.4 Million
- Q4 2024
A detailed history of Velan Capital Investment Management LP transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Velan Capital Investment Management LP holds 150,000 shares of ITCI stock, worth $19.7 Million. This represents 6.09% of its overall portfolio holdings.
Number of Shares
150,000Holding current value
$19.7 Million% of portfolio
6.09%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ITCI
# of Institutions
419Shares Held
88.8MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.28 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$832 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$675 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$428 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$423 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...